Improved Quality of Life in Children With Intestinal Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-02

Study Completion Date

2023-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Children with intestinal failure have a lack of tolerance for food in the intestine. The children are dependent on intravenous nutrition over a long period of time period to ensure growth and development. The condition is characterized by bacterial overgrowth in the intestine, with nausea, vomiting, diarrhea and flatulence as physical symptoms. Mental health is affected in the form of lower quality of life, lack of school participation and less social contact with peers. The investigators own (unpublished) data show that children with intestinal failure have a lower quality of life than healthy people. Standard treatment is antibiotics, but the effect of these is short-lived, and many must have repeated courses. Prebiotics are indigestible carbohydrates (fiber) in foods that positively affect the bacterial flora and promote intestinal health. In this project the investigators want to see if supply of prebiotics can change the bacterial balance, reduce symptoms of bacterial overgrowth and increase quality of life. The study is unique, as Prebiotics have not previously been used in the treatment of intestinal failure. If successful, it can pave the way for a new and better treatment method that can potentially be transferred to other conditions with imbalance in the intestinal flora. The study is a randomized intervention study and is consist of two phases. In phase 1, the effect of 4 weeks of open intervention with prebiotics is studied to establish so-called "proof of concept". Data from phase 1 are used to look at connections between the composition of intestinal flora, nutritional status and bowel function. The intervention involves the use of a prebiotic product (Stimulance, Nutricia), which is added to childs regular food. In phase 2, patients are randomized into two groups. One group will continue with the product for 6 months, while the other group does not receive prebiotics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

NCT04629014

Pediatric Intestinal Failure

RECRUITING

Three Dietary Regimens in Pre-colonoscopic Bowel Preparation in Children

NCT05609591

Bowel Preparation

COMPLETED NA

A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children

NCT01823848

Functional Constipation

TERMINATED NA

Exploring Food Rejection Dispositions as Potential Risk Factors for Undernutrition in Hospitalized Children Aged 2 to 8

NCT06330025

Undernutrition

COMPLETED

Effects of Butyrate Against Pediatric Obesity

NCT04620057

Obesity, Childhood

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Quality of life, gastrointestinal symptoms and family impact are measured using validated forms for four weeks before intervention phase 1, at start-up and after phase 1, as well as after phase 2. Stool samples are collected at the same time points. Weight, height is measured and blood tests are collected at the start and end of phases 1 and 2. Data on diet and nutritional treatment are collected at the start and end of the two phases. The stool samples are analyzed for short fatty acids (marker for good intestinal health), the composition of the intestinal flora and inflammation markers. Blood samples are analyzed for infection markers, intestinal health markers and nutritional markers. Nutritional data are analyzed for nutrient content and the dependence on nutritional support is calculated.

The investigators expect that the study will lead to an improved quality of life for the patient group through increased tolerance to food in the intestine, reduced antibiotic use and reduction of gastrointestinal symptoms. The project is patient-oriented.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intestinal Pseudo-Obstruction Short Bowel Syndrome Malabsorption Syndrome Autoimmune Enteropathy Bacterial Overgrowth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Intervention with prebiotics to all participants for 4 weeks. Then randomisation to continue with prebiotics for 6 months or no intervention.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stimulance

4 weeks intervention with Stimulance for all participants

Group Type EXPERIMENTAL

Stimulance

Intervention Type DIETARY_SUPPLEMENT

Intervention with Prebiotic supplement

Stimulance 6 months

6 months intervention

Group Type EXPERIMENTAL

Stimulance

Intervention Type DIETARY_SUPPLEMENT

Intervention with Prebiotic supplement

No intervention

6 months control group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stimulance

Intervention with Prebiotic supplement

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with congenital malformations or diseases requiring intestinal surgery leading to short bowel syndrome or
* Diagnosed with conditions and diseases leading to intestinal failure e.g pseudo obstruction.

And Treated with parenteral nutrition for minimum 60 days within a 74 day period.

Exclusion Criteria

* Children in need of temporary advanced nutrition intervention due to illness, e.g. infections.
* Children with temporary malfunctioning gut due to advanced medical treatment, for example cancer treatment or transplantation

Minimum Eligible Age

1 Year

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No